Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Thiopurine methyltransferase (TPMT) enzyme plays a key role in the metabolism of azathioprine/6-mercaptopurine (6-MP). Mutations in the enzyme lead to generation of excess thioguanine, which causes suppression of various cell lineages, especially neutrophils. Data on the prevalence of TPMT polymorphism are available from Western and some Asian countries; such data from India are sparse.

Aims

The aim of this research is to study the prevalence of TPMT mutation in Indian patients requiring immunomodulator therapy and its relation to the development of neutropenia on azathioprine therapy.

Methods

In this retrospective study, data of all patients who underwent TPMT genotyping by PCR-RFLP and allele-specific PCR prior to immunomodulator therapy were analyzed. The frequency of on-treatment development of neutropenia (total neutrophil count <1,500 per cubic millimeters) was noted.

Results

Data were available on 126 patients (mean age, 42 [SD 13.6] years; 73 men and 53 women). The disease indications included ulcerative colitis (61), Crohn's disease (43), indeterminate colitis (1), autoimmune hepatitis (16), and others (5). TPMT genotype was wild in 120 patients (95.23 %) and heterozygous in 6 patients (4.77 %); no patient had homozygous mutation. Seven of 87 patients (6.8 %) who received azathioprine developed neutropenia; blood counts normalized on cessation of the drug in all. The incidence of neutropenia in patients with wild type was 6/84 (7.14 %) and with heterozygous type 1/3 (33 %) (p = 0.5764).

Conclusion

Nearly 5 % of this population of patients requiring immunomodulator therapy was heterozygous carriers of the TPMT gene. Neutropenia was equally common in patients without and with the mutation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lennard L, Vanloon JA, Weinshiboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther. 1989;46:149–54.

    Article  CAS  PubMed  Google Scholar 

  2. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol. 1992;43:329–39.

    Article  CAS  PubMed  Google Scholar 

  3. Ford LT, Berg JD. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come. J Clin Pathol. 2010;63:288–95.

    Article  CAS  PubMed  Google Scholar 

  4. Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst. 1999;91:2001–8.

    Article  CAS  PubMed  Google Scholar 

  5. Glissen LP, Wong DR, Engels LG, et al. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine-tolerant IBD patients on maintenance therapy. J Crohns Colitis. 2012;6:698–707.

    Article  Google Scholar 

  6. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608–14.

    Article  CAS  PubMed  Google Scholar 

  8. Stocco G, Martelossi S, Decorti G, et al. Pharmacogenetics of thiopurines: can posology be guided by laboratory data? Radiol Oncol. 2004;38:101–9.

    CAS  Google Scholar 

  9. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Gen. 1980;32:651–62.

    CAS  Google Scholar 

  10. Relling MV, Gardner EE, Sandborn WJ, et al. Clinical pharmacogenetics implementation: consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther. 2011;89:387–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Alves S, Amorim A, Ferreira F, et al. Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity. Clin Pharmacol Ther. 2001;70:165–74.

    Article  CAS  PubMed  Google Scholar 

  12. Alves S, Ferreira F, Prata MJ, Amorim A. Characterization of three new VnTR alleles in the promoter region of the TPMT gene. Hum Mutat. 2000;15:121.

    Article  CAS  PubMed  Google Scholar 

  13. Alves S, Prata MJ, Ferreira F, Amorim A. Screening of thiopurine S-methyltransferase mutations by horizontal conformation-sensitive gel electrophoresis. Hum Mut. 2000;15:246–53.

    Article  CAS  PubMed  Google Scholar 

  14. Alves S, Rocha J, Amorim A, Prata MJ. Tracing of the origin of the most common thiopurine methyltransferase (TPMT) variants: preliminary data from the patterns of haplotypic association with two CA repeats. Ann Hum Gen. 2004;68:313–23.

    Article  CAS  Google Scholar 

  15. Alves S, Rocha J, Amorim A, Prata MJ. Evolution of a VnTR located within the promoter region of the thiopurine methyltransferase gene: inferences from population and sequence data. Hum Gen. 2002;111:172–8.

    Article  CAS  Google Scholar 

  16. Schaeffeler E, Lang T, Zanger UM. High-throughput genotyping of thiopurine S-methyltranferase by denaturing HPLC. Clin Chem. 2001;47:548–55.

    CAS  PubMed  Google Scholar 

  17. Schaeffeler E, Stanulla M, Greil J. A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALL leukaemia. Leukemia. 2003;17:1422–4.

    Article  CAS  PubMed  Google Scholar 

  18. Schwab M, Schaeffeler E, Marx C. Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only. Gastroenterology. 2001;121:500–1.

    Article  Google Scholar 

  19. Schwab M, Schaffeler E, Marx C. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphisms. Pharmacogenetics. 2002;12:429–36.

    Article  CAS  PubMed  Google Scholar 

  20. Dauer M, Schulze J, Loher F. Determination of thiopurine S-methyltransferase phenotype using thin-layer chromatography and quantitative scanning. Eur J Clin Pharmacol. 2002;58:41–4.

    Article  CAS  PubMed  Google Scholar 

  21. Wood N, Fraser A, Bidwell J. RT-PCR permits simultaneous genotyping of thiopurine S-methyltransferase allelic variants by multiplex-induced heteroduplex analysis. Hum Mut. 2004;24:93–9.

    Article  CAS  PubMed  Google Scholar 

  22. Langley PG, Underhill J, Tredger JM, Norris S, McFarlane IG. Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J Hepatol. 2002;37:441–7.

    Article  CAS  PubMed  Google Scholar 

  23. Ashavaid TF, Raghavan R, Shah S, Kapadia A, Almel S, Desai D. TPMT and DPD polymorphisms: efficient screening method for Indian patients considering taking thiopurine and 5-FU drugs. Dis Markers. 2009;27:231–8.

    Article  CAS  PubMed  Google Scholar 

  24. Kapoor G, Maitra A, Somlata Brahmachari V. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism. Indian J Med Res. 2009;129:500–5.

    CAS  PubMed  Google Scholar 

  25. Desire S, Balasubramanian P, Bajel A, et al. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine. Med Oncol. 2010;27:1046–9.

    Article  CAS  PubMed  Google Scholar 

  26. Murugesan R, Vahab SA, Patra S, et al. Thiopurine S-methyltransferase alleles, TPMT(*)2, (*)3B and (*)3C, and genotype frequencies in an Indian population. Exp Ther Med. 2010;1:121–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  27. Kapoor G, Sinha R, Naithani R, Chandgothia M. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia. Leuk Res. 2010;34:1023–6.

    Article  CAS  PubMed  Google Scholar 

  28. Umamaheswaran G, Krishna Kumar D, Kayathiri D, et al. Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the south Indian population. Mol Biol Rep. 2012;39:6343–51.

    Article  CAS  PubMed  Google Scholar 

  29. Iyer SN, Tilak AV, Mukherjee MS, Singhal RS. Genotype frequencies of drug-metabolizing enzymes responsible for purine and pyrimidine antagonists in a healthy Asian-Indian population. Biochem Genet. 2012;50:684–93.

    Article  CAS  PubMed  Google Scholar 

  30. Dorababu P, Nagesh N, Linga VG, et al. Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia. Eur J Clin Pharmacol. 2012;68:379–87.

    Article  CAS  PubMed  Google Scholar 

  31. Lennard L. TPMT in the treatment of Crohn's disease with azathioprine. Gut. 2002;51:143–6.

    Article  CAS  PubMed  Google Scholar 

  32. Connel WR, Kamm KA, Ritchie JK, Lennard Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut. 1993;34:1081–5.

    Article  Google Scholar 

Download references

Acknowledgments

We acknowledge Shweta Bhawalkar for providing her help in the data and references in TPMT genotypes.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai, 400 016, India

    Sandeep Kirit Davavala, Devendra C. Desai, Philip Abraham, Anand Joshi & Tarun Gupta

  2. Department of Biochemistry, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai, 400 016, India

    Tester Ashavaid

Authors
  1. Sandeep Kirit Davavala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Devendra C. Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tester Ashavaid
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anand Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tarun Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandeep Kirit Davavala.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davavala, S.K., Desai, D.C., Abraham, P. et al. Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance. Indian J Gastroenterol 33, 41–45 (2014). https://doi.org/10.1007/s12664-013-0374-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-013-0374-6

Keywords

Search

Navigation